Navigation Links
Perrigo Nutritionals Works with the American Academy of Pediatrics (AAP) on Infant Nutrition Educational Initiative
Date:8/5/2013

ALLEGAN, Mich., Aug. 5, 2013 /PRNewswire/ -- Perrigo Company (NYSE: PRGO; TASE) today announced that its infant formula division, Perrigo Nutritionals, is working with the American Academy of Pediatrics (AAP) to increase educational awareness around infant nutrition, health, and feeding options. The relationship between the two organizations includes Perrigo's sponsorship of AAP's educational resource, HealthyChildren.org. The website offers pediatrician-approved health information and advice for parents and caregivers, along with interactive tools and personalized content.

(Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO )

Perrigo's Chairman, President and CEO Joseph C. Papa stated, "Today's parents and caregivers are faced with confusing health information, and nowhere is this truer than in the areas of infant nutrition and infant feeding options. Reports have surfaced of caregivers diluting infant formula to save money. This poses a public health risk because it reduces the amount of nutrients an infant requires. Our aim is to work with the American Academy of Pediatrics to provide accurate health and nutrition information on breastfeeding and formula feeding so that parents can improve the health of their families. Perrigo remains committed to providing quality products at affordable prices for consumers around the globe."

The American Academy of Pediatrics (AAP) and its member pediatricians dedicate their efforts and resources to the health, safety and well-being of infants, children, adolescents and young adults. The AAP has approximately 60,000 members in the United States, Canada, Mexico, and many other countries. Members include pediatricians, pediatric medical subspecialists and pediatric surgical specialists. More than 45,000 members are board-certified and called Fellows of the American Academy of Pediatrics (FAAP). For more information, visit http://www.healthychildren.org.

Perrigo Nutritionals produces Store Brand Infant Formulas in Vermont and Ohio, U.S.A. The company's FDA-inspected, ISO 9001:2008-certified facilities have been producing formulas for more than 30 years in strict compliance with good manufacturing practices (GMP). For more information, visit Perrigo infant formula websites at http://www.perrigonutritionals.com and http://www.storebrandformula.com.  

From its beginnings as a packager of generic home remedies in 1887, Allegan, Michigan-based Perrigo Company has grown to become a leading global provider of quality, affordable healthcare products. Perrigo develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements and active pharmaceutical ingredients (API). The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of logistics operations have evolved over the years to include the United States, Israel, Mexico, the United Kingdom, India, China and Australia. Visit Perrigo on the Internet (http://www.perrigo.com). 

Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential" or other comparable terminology. The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections.  While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company's control. These and other important factors, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended June 30, 2012, as well as the Company's subsequent filings with the Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements in this press release are made only as of the date hereof, and unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Perrigo
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Perrigo Company Will Release Fourth Quarter And Fiscal Year 2013 Results On August 15, 2013
2. Perrigo Receives FDA Tentative Approval For Generic Equivalent To Prandin(R)
3. Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharmaceuticals, LLC For An Upfront Payment Of $93 Million
4. New Breakthroughs Allow Companies to Expand their Reach - Research Report on Perrigo, Auxilium, Actavis, Mylan, and Salix
5. Perrigo Launches First-Ever Industry Marketing Campaign For Store Brand OTC Medications
6. Perrigo Reports Record Revenue and Adjusted Earnings
7. Perrigo Company To Release Third Quarter Fiscal Year 2013 Results On May 7, 2013
8. Perrigo Company To Present At The Barclays Global Healthcare Conference
9. Perrigo Company To Present At The RBC Global Healthcare Conference
10. Perrigo Confirms First to File Patent Challenge for Generic Version of Testosterone Gel 1.62%
11. Perrigo Company To Present At The Leerink Swann Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):